'Feeding and fasting' hormone adropin can improve insulin action

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
In a study published in Molecular Metabolism, a SLU researcher has found that adropin, a hormone that regulates whether the body burns fat or sugar during feeding and fasting cycles, can improve insulin action in obese, diabetic mice, suggesting that it may work as a therapy for type 2 diabetes.

According to the American Diabetes Association, 29.1 million Americans have diabetes, while 86 million Americans age 20 and older are thought to have a 'pre-diabetic' condition that includes increased fasting glucose and/or "impaired glucose tolerance." The numbers have been growing along with the country's obesity epidemic.

http://www.eurekalert.org/pub_releases/2015-01/slu-af012915.php
 
Status
Not open for further replies.
Back
Top